Detailed information for compound 263377

Basic information

Technical information
  • TDR Targets ID: 263377
  • Name: 2-(3-iodoprop-2-ynyl)-5-(4-methoxyphenyl)tetr azole
  • MW: 340.12 | Formula: C11H9IN4O
  • H donors: 0 H acceptors: 3 LogP: 2.77 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: IC#CCn1nnc(n1)c1ccc(cc1)OC
  • InChi: 1S/C11H9IN4O/c1-17-10-5-3-9(4-6-10)11-13-15-16(14-11)8-2-7-12/h3-6H,8H2,1H3
  • InChiKey: XAPJGEFYCBBFND-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-(3-iodoprop-2-ynyl)-5-(4-methoxyphenyl)-1,2,3,4-tetrazole
  • AIDS-154270
  • AIDS154270
  • 2H-Tetrazole, 2-(3-iodo-2-propynyl)-5-(4-methoxyphenyl)-

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi dihydroorotate dehydrogenase (fumarate), putative 0.0249 0.2197 1
Trichomonas vaginalis cdc25b, putative 0.0264 0.2376 1
Trichomonas vaginalis cdc25c, putative 0.0264 0.2376 1
Schistosoma mansoni m-phase inducer phosphatase(cdc25) 0.0264 0.2376 1
Brugia malayi Dihydroorotate dehydrogenase, mitochondrial precursor, putative 0.0249 0.2197 0.1914
Echinococcus multilocularis m phase inducer phosphatase(cdc25) 0.0264 0.2376 1
Toxoplasma gondii dihydroorotate dehydrogenase reveal, putative 0.0249 0.2197 1
Trichomonas vaginalis mitotic inducer phosphatase CDC25, putative 0.0264 0.2376 1
Mycobacterium leprae Probable dihydroorotate dehydrogenase PyrD 0.0249 0.2197 1
Trypanosoma cruzi dihydroorotate dehydrogenase, putative 0.0249 0.2197 1
Trypanosoma cruzi dihydroorotate dehydrogenase, putative 0.0249 0.2197 1
Entamoeba histolytica rodhanase-like domain containing protein 0.0264 0.2376 1
Onchocerca volvulus 0.0264 0.2376 0.5
Schistosoma mansoni lipoxygenase 0.0098 0.0359 0.151
Mycobacterium ulcerans dihydroorotate dehydrogenase 2 0.0249 0.2197 1
Entamoeba histolytica rodhanase-like domain containing protein 0.0264 0.2376 1
Schistosoma mansoni dihydroorotate dehydrogenase 0.0249 0.2197 0.9245
Onchocerca volvulus 0.0264 0.2376 0.5
Brugia malayi Rhodanese-like domain containing protein 0.0264 0.2376 0.21
Trichomonas vaginalis mitotic inducer phosphatase CDC25, putative 0.0264 0.2376 1
Trichomonas vaginalis m-phase inducer phosphatase, putative 0.0264 0.2376 1
Trypanosoma brucei dihydroorotate dehydrogenase (fumarate) 0.0249 0.2197 0.5
Echinococcus multilocularis arachidonate 5 lipoxygenase 0.0098 0.0359 0.0046
Echinococcus granulosus arachidonate 5 lipoxygenase 0.0098 0.0359 0.0046
Echinococcus granulosus m phase inducer phosphatasecdc25 0.0264 0.2376 1
Trichomonas vaginalis hypothetical protein 0.0161 0.1129 0.3844
Brugia malayi Rhodanese-like domain containing protein 0.0264 0.2376 0.21
Wolbachia endosymbiont of Brugia malayi dihydroorotate dehydrogenase 2 0.0249 0.2197 1
Onchocerca volvulus 0.0264 0.2376 0.5
Plasmodium vivax dihydroorotate dehydrogenase, mitochondrial precursor, putative 0.0249 0.2197 1
Loa Loa (eye worm) hypothetical protein 0.0892 1 1
Plasmodium falciparum dihydroorotate dehydrogenase 0.0249 0.2197 1
Loa Loa (eye worm) NNMT/PNMT/TEMT family protein 0.0892 1 1
Mycobacterium tuberculosis Probable dihydroorotate dehydrogenase PyrD 0.0249 0.2197 1
Brugia malayi Dihydroorotate dehydrogenase, mitochondrial precursor, putative 0.0249 0.2197 0.1914
Trichomonas vaginalis m-phase inducer phosphatase, putative 0.0264 0.2376 1
Onchocerca volvulus 0.0264 0.2376 0.5
Loa Loa (eye worm) hypothetical protein 0.0892 1 1
Trichomonas vaginalis mitotic inducer phosphatase CDC25, putative 0.0264 0.2376 1
Chlamydia trachomatis enoyl-acyl-carrier protein reductase 0.0161 0.1129 0.5
Leishmania major dihydroorotate dehydrogenase 0.0249 0.2197 0.5
Loa Loa (eye worm) hypothetical protein 0.0264 0.2376 0.0318
Loa Loa (eye worm) hypothetical protein 0.0264 0.2376 0.0318
Entamoeba histolytica rodhanase-like domain containing protein 0.0264 0.2376 1
Trichomonas vaginalis cdc25b, putative 0.0264 0.2376 1

Activities

Activity type Activity value Assay description Source Reference
MIC (functional) = 0.1 ug ml-1 Antifungal activity towards Trichophyton mentagrophytes 530324 strain ChEMBL. 3546691
MIC (functional) = 0.1 ug ml-1 Antifungal activity towards Trichophyton interdigitale ChEMBL. 3546691
MIC (functional) = 1.56 ug ml-1 Antifungal activity against Aspergillus fumigatus Saito strain ChEMBL. 3546691
MIC (functional) = 12.5 ug ml-1 Antifungal activity against Candida albicans C-A-24 strain ChEMBL. 3546691
MIC (functional) = 12.5 ug ml-1 Antifungal activity against Candida albicans C-A-24 strain ChEMBL. 3546691
MIC (functional) = 25 ug ml-1 Antifungal activity against Cryptococcus neoformans Cr-1 strain ChEMBL. 3546691
MIC (functional) = 25 ug ml-1 Antifungal activity against Cryptococcus neoformans Cr-1 strain ChEMBL. 3546691

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.